Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.

× No keyword cloud information.

7 in total

Review 1. [Treatment of advanced metastatic melanoma].

Authors: S Ugurel; J C Becker
Journal: Hautarzt Date: 2011-06 Impact factor: 0.751

2. [Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].

Authors: R Preussmann; S Ivankovic; C Landschütz; J Gimmy; E Flohr; U Griesbach
Journal: Z Krebsforsch Klin Onkol Cancer Res Clin Oncol Date: 1974

3. Investigational drugs for the treatment of malignant melanoma.

Authors: K Hellmann
Journal: Proc R Soc Med Date: 1974-02

4. Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma.

Authors: C I Falkson
Journal: Med Oncol Date: 1995-03 Impact factor: 3.064

5. Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.

Authors: D A Amato; H Bruckner; D Guerry; A Ash; G Falkson; E C Borden; R H Creech; E D Savlov; T J Cunningham
Journal: Invest New Drugs Date: 1987 Impact factor: 3.850

6. Effects of prolonged treatment with decarbazine on tumor metastatic potential in mice bearing Lewis lung carcinoma.

Authors: S Zorzet; L Perissin; V Rapozzi; S Pacor; T Giraldi
Journal: Clin Exp Metastasis Date: 1995-03 Impact factor: 5.150

7. Methyl Gallate Suppresses Tumor Development by Increasing Activation of Caspase3 and Disrupting Tumor Angiogenesis in Melanoma.

Authors: Jeong-Ki Park; Min-Jae Yoo; Hyuk Jang; Sang-Youel Park; Jawun Choi; Jae-Won Seol
Journal: Evid Based Complement Alternat Med Date: 2022-09-06 Impact factor: 2.650

7 in total